CONCERT PRESENTS DURING LATE-BREAKING NEWS SESSION AT EADV 2019 CONGRESS

October 12th, 2019

 

Concert Pharmaceuticals presented during the late-breaking news session at the European Academy of Dermatology and Venereology (EADV) Annual Congress on Saturday, October 12, 2019 in Madrid, Spain. The presentation focused on data from a recently completed Phase 2 dose ranging clinical trial of CTP-543, an investigational treatment being developed for alopecia areata.

About EADV

EADV is a non-profit association dedicated to advancing patient care, education and research in the field of dermatology and venereology by providing a unique platform to bring people together and share ideas. Founded in 1987, EADV is the leading community to further the knowledge of health professionals and advocates in the field of dermatology and venereology. EADV organizes annually one main congress in one of the European capitals.

 

Back to Top